Egyptian study finds weekly diabetes medication better for teens
An Egyptian study led by Ain Shams University has shown that the weekly use of Dulaglutide, a GLP-1 receptor agonist, outperforms daily insulin in treating a rare type of diabetes linked to beta-thalassemia in teenagers. The results demonstrated that administering the medication significantly improved blood sugar control and reduced fluctuations without causing weight gain, while also decreasing the likelihood of iron accumulation in the body, which is a major cause of this diabetes type. The study emphasizes that this treatment can enhance the body's ability to produce natural insulin, especially since the diabetes results from pancreatic damage caused by iron buildup. However, further future trials are necessary to confirm its effectiveness.
Notice: This Is an AI-Generated Summary
Comments (0)